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Introduction
Hyperoxia induced hypercapnia has been described more
than 60 years ago [1] and first recommendations to avoid
hyperoxia in COPD patients were provided more than
50 years ago [2]. Alarm bell was recently raised [3] after
the demonstration that high oxygen flows could increase
mortality in patients with respiratory distress [4].
Objectives
To develop a device continuously adjusting Fi02 with high
flows of air/oxygen based on the Free02 system that
titrates oxygen flow delivered to patients with the aim to
maintain a constant oxygenation [5].
Methods
The Free02 system was modified to allow a mixture of
oxygen and air administration with a constant gas flow.
The proportion of oxygen is based on an advanced closed
loop to maintain a constant Sp02. We compare this new
prototype with Optiflow set with minimal Fi02 (35%).
Both devices are set at 30L/min, and we plan to recruit 10
healthy subjects’. The experimental conditions are the
following: healthy subjects will initially breath room air
(5 minutes), followed by 5 minutes of induced hypoxemia
(nitrogen administration), and return to initial conditions
(breathing room air for 5 minutes). We record Sp02,
respiratory rate, heart rate and Fi02 delivered.
Results
We will present results of this comparison in 10 healthy
subjects. Initial data demonstrate the feasibility to deliver
variable oxygen flows administered with air at high flows
(from 20 to 60L/min). In this study, the flow is maintained
constant at 30L/min. During nitrogen administration to
the healthy subjects, with the new prototype controlling
oxygen/air administration, the oxygen increases (leading
to a Fi02 increase) to maintain constant the Sp02 level
(set at 94% in this study), and the air flow decreases to
maintain constant the total flow (30L/min). After cessation
of nitrogen, the oxygen flow (and Fi02) are automatically
reduced (Figure). In the first included subjects, with
Optiflow. hyperoxia is present during the first and third
condition (breathing room air) and hypoxemia occur
during nitrogen administration.
Conclusions
This new device may help to optimize oxygenation avoid-
ing hypoxemia and hyperoxia during high flow oxygen
therapy.
1Institut Universitaire de Cardiologie et de Pneumologie de Québec, Lac-
Beauport, Canada
Full list of author information is available at the end of the article
Figure 1 Automatic adjustment of the Fi02.
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